<DOC>
	<DOCNO>NCT00834509</DOCNO>
	<brief_summary>The purpose study : - recruit subject untreated sleep apnea ; ass overnight change blood urine chemical - review overnight change blood urine chemical treat sleep apnea - ass overnight change blood urine chemical healthy individual sleep problem - compare amount fat belly use Magnetic Resonance Imaging ( MRI ) scanner subject</brief_summary>
	<brief_title>Biomarkers Obstructive Sleep Apnea</brief_title>
	<detailed_description>The overall goal project address postulate optimal molecular signature common disorder obstructive sleep apnea ( OSA ) change relevant biomarkers sleep period . In sleep apnea , event lead sleep fragmentation cyclical deoxygenation/reoxygenation . It propose change lead molecular consequence detect assess biomarkers blood . To determine change due OSA circadian/sleep mechanism , study do patient OSA effective treatment Continuous Positive Airway Pressure ( CPAP ) also control similar visceral adiposity without OSA . Multiple assessment biomarkers make , sleep . Since propose magnitude dynamic change across sleep period affect degree visceral obesity great OSA subject cardiovascular comorbidities , study do 4 group subject : lean obese without morbidity . In assess biomarkers primary outcome variable : urinary isoprostanes ( oxidative stress ) ; plasma tumor necrosis factor alpha ( TNFα ) ( inflammation ) ; plasma norepinephrine ( sympathetic activation ) ; free fatty acid . Secondary biomarkers : Interleukin 6 ( IL-6 ) , urinary norepinephrine ; urinary normetanephrine ; glucose , Intercellular Adhesion Molecule ( ICAM ) , leptin . To complement assessment circulate biomarkers , approach utilize cellular window use . Monocytes separate blood sample ( , sleep ) RNA extract . Expression key gene assess RT-PCR microarray study perform subset subject assess change expression gene result OSA . A particular focus investigate difference individual OSA without cardiovascular comorbidities . Three aspect evaluate : ) whether individual comorbidities oxidative stress inflammatory change equivalent degree OSA individual without comorbidities ; b ) whether individual comorbidities low level protective mechanisms—melatonin ( anti-oxidant secrete sleep ) , IL-10 ( antiinflammatory ) ; c ) different gene variant base genetic association study use recently develop CV SNP array . Finally , data use determine whether diagnostic urine and/or blood test OSA .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>able read write English female , pregnant go bed 9:30pm12:30am sleep minimum 7 hours/night telephone access BMI &lt; 40 shift worker , irregular schedule previous diagnosis sleep disorder OSA previous treatment CPAP , BiPAP , oxygen , surgery OSA current kidney disease , anemia , depression , substance abuse/dependence BMI &gt; 40 visual/hearing/cognitive impairment smoker 's willing refrain nicotine study willing try CPAP treatment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>